STING1 and cholangiocarcinoma: GEPIA web-based tool was used to evaluate the mRNA expression of cGAS-STING pathway-related molecules in gastrointestinal cancers, including CCA, PAAD, liver hepatocellular carcinoma (LIHC), colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), rectum adenocarcinoma (READ), and stomach adenocarcinoma (STAD).